Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiauranib in Advanced Soft Tissue Sarcoma
NCT05497843Phase 2Completed
- Sponsor
- Akeso, Inc.
- Start
- Aug 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chiauranib in soft tissue sarcoma (STS), sponsored by Akeso, Inc.. Started Aug 2022; status: completed.
02
Drugs
chiauranib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05497843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05497843.